National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
For Patients
Latest Drugs
Midostaurin (Rydapt®) for ASM -
September 10, 2018
Midostaurin (Rydapt®) for AML -
September 10, 2018
Idebenone (Raxone®) -
August 30, 2018
Ocrelizumab (Ocrevus®) for RMS -
August 29, 2018
Pembrolizumab (Keytruda®) 1L NSCLC with chemotherapy -
August 29, 2018
Lenvatinib (Lenvima®) for HCC -
August 16, 2018
Erenumab (Aimovig®) -
August 15, 2018
Ribociclib (Kisqali®) -
August 13, 2018
Osimertinib (Tagrisso®) for the first-line treatment of metastatic NSCLC -
August 7, 2018
Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of adults with melanoma -
July 27, 2018
« First
Previous Page
...
2
3
4
5
6
7
8
9
10
11
...
20
30
40
...
Next Page
Last »
health check
